$10.98
+0.23 (+2.14%)
Open$10.68
Previous Close$10.75
Day High$11.00
Day Low$10.31
52W High$18.20
52W Low$2.88
Volume—
Avg Volume86.4K
Market Cap23.94M
P/E Ratio—
EPS$-5.64
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.61M | 10.68M | 9.55M |
| Net Income | 789.2K | 807.9K | 770.6K |
| Profit Margin | 7.4% | 7.6% | 8.1% |
| EBITDA | 1.40M | 1.47M | 1.23M |
| Free Cash Flow | 547.8K | 770.2K | 737.4K |
| Rev Growth | -2.0% | +19.5% | +10.5% |
| Debt/Equity | 0.36 | 0.38 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |